Where I see patients (1)
My reviews
Selected research
-
Reduced dosing of lenvatinib with pembrolizumab for advanced endometrial cancer.
Gynecologic oncology
-
Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702.
Leukemia
-
Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study.
Blood
4.8